Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Capital Expenditures (2016 - 2025)

Ingevity (NGVT) has disclosed Capital Expenditures for 11 consecutive years, with -$600000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Capital Expenditures rose 95.95% to -$600000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $78.1 million, a 21.09% increase, with the full-year FY2025 number at $57.7 million, down 25.64% from a year prior.
  • Capital Expenditures was -$600000.0 for Q2 2025 at Ingevity, down from $2.9 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $137.4 million in Q4 2022 to a low of -$52.1 million in Q3 2022.
  • A 5-year average of $24.2 million and a median of $20.8 million in 2024 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 7500.0% in 2022; the steepest drop was 182.31% in 2022.
  • Ingevity's Capital Expenditures stood at $37.4 million in 2021, then skyrocketed by 267.38% to $137.4 million in 2022, then decreased by 24.53% to $103.7 million in 2023, then plummeted by 75.99% to $24.9 million in 2024, then crashed by 102.41% to -$600000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Capital Expenditures are -$600000.0 (Q2 2025), $2.9 million (Q1 2025), and $24.9 million (Q4 2024).